Research Progress on Preparation, Transformation and Application of Protoplasts Derived from Medicinal Plants Authors: Zijin Fang, Yanheng Hu, Zijing Zhou, Huijie Ma, Lingxiao Zhang, Yuting Peng, Xiaori Zhan, Yiming Sun, Chenjia Shen Published: 2026 ABSTRACT As unicellular systems, protoplasts derived from medicinal plant cells exhibit high totipotency and hold significant value in applications such as gene function analysis, genetic improvement, and cell engineering optimization. This review focuses on how protoplast technology addresses longstanding bottlenecks in medicinal plant research by systematically collating recent advances in the study of medicinal plant protoplasts. It explores the multifaceted factors influencing protoplast preparation, including the intrinsic and extrinsic properties of medicinal plant materials, pretreatment methods prior to enzymatic hydrolysis, the composition of enzymatic solutions, enzymatic hydrolysis parameters, external environmental conditions, and protoplast purification techniques. Additionally, the review summarizes the significance and value of medicinal plant protoplasts in gene function verification, gene editing, genetic transformation, single-cell sequencing, and cell fusion regulation. By comprehensively synthesizing the optimization of the preparation of medicinal plant protoplasts and their application in transient expression, gene function research, and plant regeneration, this work aims to provide critical guidance for subsequent research in genetic modification, germplasm resource breeding, spatiotemporal programming of active substances, and regulatory network analysis. Ultimately, it serves as a valuable reference for advancing research in the plant sciences. 1. Dilemmas Faced in Medicinal Plant Research Medicinal plants refer to plants containing one or more active ingredients, which usually have potential therapeutic value or serve as sources for drug isolation [1]. Among more than 1300 natural medicines used in Europe, 90% are derived from wild medicinal plant resources; of the top 150 prescription drugs used in the United States, approximately 118 originate from natural medicinal components [2]. Due to their rich content of various key bioactive substances, medicinal plants can be applied in healthcare maintenance, disease treatment, prevention, and other medical security aspects [3]. The accumulation of bioactive compounds in medicinal plants is not only regulated by internal physiological factors, such as variety, age, developmental stage, and organ differences, but also jointly affected by external environmental conditions, such as light, temperature, and geographical origin [3,4]. Due to common dilemmas, such as restrictions on the extraction of pharmacologically active ingredients, long growth cycles of plant materials, and difficulties in genetic transformation, studies on gene function verification, genetic improvement, and metabolic regulation of medicinal plants have been relatively backward [5,6,7,8]. The application of medicinal plant protoplasts helps to analyze the functions of genes related to the biosynthesis of active ingredients, which provide resources for genetic improvement. Furthermore, protoplast technology also realizes large-scale separation and extraction of active ingredients through regenerative culture, thus breaking through the limitations of conventional breeding [9]. Secondary metabolites in medicinal plants, which are characterized by low natural content, limited resources, and complex chemical structures, are the main pharmacodynamically active ingredients [7]. However, the synthesis and regulation mechanisms of active ingredients in medicinal plants remain unclear. The protoplast experimental technology provides a key path for overcoming environmental dependence in the breeding process, deepening functional analysis, and promoting the production of natural active ingredients [9]. Due to the unstable content of active ingredients in medicinal plants, researchers have established and optimized medicinal plant protoplast systems under artificially controlled environments. Furthermore, the protoplast system helps to create high-quality new germplasm, quickly analyze and regulate the biosynthesis pathway of active ingredients, and establish efficient single-cell regeneration and fast propagation systems. Several medicinal plants have long life cycles, which brings many difficulties to their variety breeding and genetic improvement [5]. The rapid transient protoplast transformation system helps overcome the difficulty of the relatively long life cycles of some medicinal plants [10]. For decades, protoplasts have been used to expand genotypic diversity through interspecific and intraspecific hybridization. The medicinal plant protoplast systems play important roles in three terms: accelerating functional gene verification (Ginkgo biloba L., Uncaria rhynchophylla, Eucommia ulmoides Oliver, and Taxus), creating new germplasms (Bletilla striata, Rhodiola sachalinensis, and Crocus sativus L.), and providing materials for genetic improvement (G. biloba, U. rhynchophylla, Macleaya cordata, Ilex rotunda Thunb., Lonicera japonica, Rh. sachalinensis, and B. striata) [11,12,13,14,15,16,17,18,19,20,21,22]. Establishing an efficient genetic transformation system is crucial for analyzing the biosynthetic mechanisms of active ingredients in medicinal plants [23]. To overcome the common dilemma that most medicinal plants lack a mature genetic transformation system, a number of protoplast transformation systems have been established. This paper systematically reviews the limitations of medicinal plants in active ingredient synthesis, cultivation cycle, and genetic transformation, summarizes the history, preparation methods, and application of medicinal plant protoplasts, aiming to break through the bottlenecks in medicinal plant research and provide new materials for genetic improvement and metabolic analysis. 2. Research History of Protoplast Preparation in Medicinal Plants In 1880, Hanstein first proposed a protoplast, referring to the “living substance”, which is a plant cell whose cell wall can be completely or partially removed by mechanical or enzymatic methods [10,24]. Initially, protoplasts provided materials for basic research in physiology, biochemistry, and genetics [25]. Meanwhile, protoplasts are totipotent living cells that retain cellular characteristics and differentiation status, serving as excellent models for cell biology research [26]. Early studies on protoplasts were mostly focused on model plants or cash crops with clear genetic backgrounds [27]. In 1892, Klercker first used a mechanical method to remove the cell wall of algae to prepare protoplasts [28]. In 1960, British scientist Cocking successfully used an enzymatic method to efficiently and gently degrade the cell walls from young tomato root tips, obtaining a large number of highly active and regenerable protoplasts [29]. In 1970, Nagata and Takebe successfully prepared protoplasts from tobacco mesophyll tissue using an enzymatic method and created regenerated plants using protoplasts [30,31]. In 1972, Carlson et al. adopted protoplast fusion technology to successfully cultivate interspecific hybrids of the Nicotiana genus [32]. In 1978, Melchers et al. used PEG-induced fusion to incubate protoplasts of tomato and potato, successfully obtaining intergeneric hybrids [33]. The above three protoplast fusion studies overcame the incompatibility of distant hybridization and provided a technical paradigm for subsequent variety improvement and germplasm optimization. In 1975, Gosch et al. isolated protoplasts derived from Atropa belladonna L. cell suspension cultures using an enzymatic method and established a regeneration system, marking the beginning of medicinal plant protoplast research [34]. In the same year, Schieder isolated protoplasts from Datura innoxia Mill. mesophyll cells [35]. Most medicinal plants contain high concentrations of secondary metabolites, such as phenols, alkaloids, and terpenoids, which easily interact with cell wall-degrading enzymes, affecting the efficiency of protoplast isolation [36]. Plant protoplasts can be isolated from various tissues, including leaves, calli, and suspension-cultured cells, while protoplast preparation mainly uses leaves as source materials [37]. Recently, great progress has been made in protoplast isolation from leaves of medicinal plants, such as Areca catechu, Ricinus communis L., and Cannabis sativa L. [38,39,40,41]. A small number of medicinal plants, such as Angelica gigas Nakai, Chrysanthemum morifolium ‘White ND’, and Pinellia ternata (Thunb.) Breit has completed whole-plant regeneration from protoplasts [25,42,43]. With protoplast fusion technology, intergeneric hybrids have been obtained from medicinal plants fused with model plants, such as combinations of Nicotiana tabacum L./A. belladonna, Nicotiana undulata L./Lycium barbarum L., D. innoxia/A. belladonna, and Duboisia myoporoides/Duboisia hopwoodii [44,45,46,47,48,49]. Gene editing has been successfully implemented in medicinal plant protoplasts, such as Salvia miltiorrhiza and C. sativa [24,50,51]. Medicinal plants undergo single-cell sequencing studies by preparing protoplasts, such as Catharanthus roseus and Nepeta tenuifolia [36,52]. However, the application of protoplasts derived from medicinal plants is still limited. 3. Preparation and Purification of Protoplasts from Medicinal Plants 3.1. Preparation of Protoplasts from Medicinal Plants Protoplast preparation is the primary step for transformation, cell culture, and subsequent applications. The protoplast preparation process is susceptible to tissue physiology; therefore, a thin cell wall, easy enzymatic hydrolysis, and high homogeneity are regarded as the main points for protoplast preparation [37]. There are two main preparation methods: the mechanical method (also called the physical method) and the enzymatic method (also called the chemical method) [53]. In early studies, the mechanical method was the primary approach for protoplast preparation [54]. Due to the limitations in cell type, operational difficulty, and osmotic pressure control, the mechanical method yields protoplasts with low efficiency and causes significant cell damage, greatly limiting its application. The enzymatic method typically involves incubating plant materials in a mixed isotonic enzyme solution capable of degrading cell walls, and then collecting viable protoplasts after the plant cell walls are disrupted [29,55]. Cellulase and pectinase are the commonly used enzymes for dissociating protoplasts from medicinal plants by targeting and digesting the main components of plant cell walls [56]. Compared with the mechanical method, the enzymatic method has several advantages, such as mild reaction conditions, high cell yield and activity, good integrity, and minimal damage to living cells. However, it is also restricted by secondary metabolites (e.g., phenols, alkaloids, terpenoids) and the specificity of enzymes. Although the enzymatic method is more suitable for plant protoplast isolation (Figure 1), the existing limiting factors urgently need to be addressed. 3.2. Purification of Protoplasts from Medicinal Plants After enzymatic hydrolysis, the sample usually contains a large amount of cellular components, such as organelles, cell debris, and protoplast fragments, which affect the viability and physiological state of protoplasts [56]. After enzymatic hydrolysis, the crude protoplast extract is generally filtered through a 40–400 mesh sieve, and the filtrate is collected for further purification by centrifugation [57]. The common purification methods for medicinal plant protoplasts mainly include centrifugation, flotation, and interface [58]. Protoplasts are sedimented by low-speed centrifugation of the filtrate (based on their high specific gravity), followed by supernatant aspiration and resuspension in washing buffer for collection [12]. This widely used method yields high protoplast numbers, but centrifugation speed must be optimized to balance quality and purity. This technology has been used to purify Acanthopanax senticosus protoplasts by low-speed centrifugation using W5 washing solution, to provide a material basis for obtaining GUS-positive seeds through the PEG-mediated transient expression system and somatic embryogenic pathway in the future [59]. Based on the difference in specific gravity between protoplasts and impurities, the flotation method uses a hypertonic washing solution to make the protoplast layer float on the liquid surface during centrifugation [60]. The flotation method can obtain protoplasts with high purity but impairs protoplast integrity, resulting in a low yield. A previous study successfully isolated C. sativa protoplast separation using a combination of W5 washing solution and 21% sucrose solution, to provide a large amount of material for subsequent subcellular localization analysis [40]. The interface method uses two solutions with significantly different osmotic concentrations, thereby forming a pure protoplast band at the liquid interface [12]. A typical application is the purification of C. morifolium ‘White ND’ protoplasts using sucrose solutions of CPW salt solution and different concentrations, and obtained a green floating protoplast band at the interface between sucrose and washing solution, successfully purifying the protoplasts, to provide single-cell materials for subsequent shot generation [42]. Impurity components from enzymatic hydrolysis vary among medicinal plant species, leading to differences in suitable protoplast purification methods and washing solution compositions. The advantages of centrifugation are minimal damage, a high recovery rate, and wide applicability. It is suitable for large-scale transformation culture of protoplasts and cell regeneration; flotation can only be used in small quantities for pre-experimental conversion; the interface method has high purity and can be widely used in single-cell research. It is more suitable for the transformation of small systems and the preparation of high-quality regenerated strains. Purified protoplasts with uniform morphology, quantity, and quality can be directly used for subsequent experiments. 3.3. Quality Evaluation of Medicinal Plant Protoplasts High yield and viability are critical for protoplasts and their transient expression [61]. The yield of protoplasts from medicinal plants is typically determined using the hemocytometer method [16]. The hemocytometer method has been used to determine protoplast yield in various medicinal plants, such as G. biloba, U. rhynchophylla, E. ulmoides, A. gigas, C. roseus, R. communis, C. sativa, C. morifolium, Camellia oleifera, A. senticosus, Phellodendron amurense rupr., Elettaria cardamomum Maton., Zingiber officinale Rosc., Lotus corniculatus L., Gynostemma pentaphyllum (Thunb) Makino, Dendrobium candidum Wall. ex Lindl., Codonopsis pilosula (Franch.) Nannf., Pinellia cordata N.E.Br, and Picrorhiza kurrooa [11,12,13,14,25,36,39,40,42,58,59,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79]. Protoplast viability detection mainly adopts the FDA staining method, which can specifically label living cells. This method has minimal impact on protoplast activity and basic metabolism, making it the most widely used method for detecting protoplast activity [66]. To date, the FDA staining method has been applied for protoplast viability detection in various medicinal plants, including G. biloba, U. rhynchophylla, E. ulmoides, S. miltiorrhiza, C. roseus, A. catechu, R. communis, C. morifolium, C. oleifera, A. senticosus, C. sativa, P. amurense, L. corniculatus, D. candidum, P. cordata, P. kurrooa, Z. officinale, Astragalus melilotoides Pall., Taxus canadensis, and Solanum dulcamara L. [11,12,13,14,24,36,38,39,42,58,59,63,64,66,67,69,70,72,75,76,77,78,79,80,81,82,83]. 4. Main Factors Affecting the Preparation of Protoplasts from Medicinal Plants The preparation of medicinal plant protoplasts is a complex process that involves the synergistic action of multiple parameters. Different preparation and purification schemes can alter the physiological state, yield, and activity of protoplasts, ultimately affecting their genetic transformation, gene editing, plant regeneration, and single-cell analysis for subsequent research. 4.1. Intrinsic Variables 4.1.1. Species of Medicinal Plants Before protoplast isolation, plant materials must be strictly screened to avoid using those plant tissues infected by pathogens or in poor growth conditions [84]. The properties of plant materials for protoplast isolation include internal factors, such as inherent genetic characteristics, age, and tissue origin, as well as external factors, such as temperature, light, and humidity, all of which affect the yield and activity of the isolated protoplasts [10]. Plant cells are encased by rigid, semipermeable cell walls made up of complex polysaccharide matrices [85]. Marked interspecific and inter-tissue variations in cell wall constituents, including cellulose and pectin contents, necessitate the selection of different cell wall-degrading enzymes, as well as adjustment and optimization of enzyme proportions and digestion conditions to maximize protoplast isolation efficiency [54,86]. Different medicinal plants have distinct genetic backgrounds, and even different varieties of the same species possess varied genotypes, which exert significant impacts on the protoplast preparation processes. Comparative variety experiments fully confirmed this genotype-dependent characteristic. Under identical experimental conditions, significant differences were observed in petal protoplast yield and activity among three C. morifolium cultivars, including ‘Zi Fengche’ [69]. 4.1.2. Growth State of Plant Materials The growth state of plant materials serves as a key intrinsic variable determining protoplast isolation efficiency and quality in medicinal plants. For the plants using leaves as materials, mature leaf tissues can yield protoplasts with higher production and vitality [87]. Nevertheless, such a tissue-dependent pattern exhibits marked species-specificity due to inherent tissue traits. In the woody medicinal plant Taxus, only young needles can generate protoplasts, whereas mature needles fail to do so, although the protoplast yield from young needles remains relatively low [15]. Thus, the inherent genetic characteristics of the plant are crucial for successful protoplast isolation. 4.1.3. Tissues of Plant Materials The tissue source significantly affects the protoplast yield and activity. The tissue sources of plant materials include vegetative organs (e.g., leaf, root, stem), reproductive organs (e.g., petal), seed embryo structures (e.g., hypocotyl, cotyledon), and materials induced by tissue culture (e.g., calli, cell suspension). Leaves are the most commonly used tissue for protoplast isolation due to their easy accessibility, abundant tissue cells, ease of separation and experimental manipulation, and high reproducibility in protoplast preparation [37,88]. There is a tissue preference in selecting raw materials for protoplast preparation across different medicinal plants [89]. Young, vigorously growing tissue materials are more likely to yield high-activity protoplasts [56]. Moreover, friable embryogenic calli have a larger enzymatic hydrolysis contact area than other tissues; thus, they can achieve more efficient protoplast release, making them more ideal materials [90]. 4.2. Process Variables 4.2.1. Pretreatment Methods Before Enzymatic Hydrolysis Prior to protoplast preparation, pretreatments are more conducive to inducing in situ dedifferentiation and disrupting the cell wall structure, thereby improving enzymatic hydrolysis efficiency and increasing protoplast yield [88]. The main pretreatment methods for medicinal plants include vacuum, dark, plasmolysis, low-temperature, and mechanical cutting treatment [91]. Vacuum and mechanical cutting belong to physical intervention-based pretreatment, whose main function is to break down the external barriers of plant tissues. Vacuum can drive the enzyme solution deep into the tissue under negative pressure, ensuring sufficient contact between the enzyme and the cells [91]. A vacuum treatment of 0.85 MPa for 30 min has been identified as an efficient condition for enzymatic digestion of E. ulmoides cell walls [14]. Mechanical cutting damages the cuticle of plant cell epidermis through peeling the epidermis, scrubbing with abrasives, or cutting organs into cross-sections, allowing enzymes for protoplast isolation to access the plant cell walls [88]. It serves as a universal pretreatment method suitable for the majority of medicinal plants. By contrast, dark, plasmolysis, and low-temperature treatment are categorized as physiological regulation-based pretreatments, with the core functions of protecting protoplast activity and reducing experimental damage. Dark treatment involves exposing plant materials to a short photoperiod to protect them from light damage and minimize the risk of photo-injury during protoplast isolation [56]. It is suitable for Dendrobium nobile protoplast isolation [92]. Plasmolysis with mannitol, sucrose, or their mixtures can achieve pre-separation of protoplasts from cell walls [56,57]. Comparative experiments between pre-plasmolysis treatment and non-pre-plasmolysis treatment have confirmed that this treatment significantly preserves L. corniculatus leaf protoplast viability [70]. Low-temperature treatment at 4 °C can alleviate mechanical and osmotic stress damage and increase the quantity and vitality of the isolated protoplasts [56]. A combined pretreatment of low-temperature dark incubation and 0.75 M mannitol immersion has been confirmed to significantly improve the yield and vitality of B. striata leaf protoplasts [16]. However, not all medicinal plant protoplast preparation studies require pretreatment. Studies have shown that high-quality protoplasts can be obtained from certain materials through simplified or even no pretreatment. For instance, protoplasts with high viability and integrity can be successfully isolated from S. miltiorrhiza leaves without any pretreatment, and mechanical cutting can be completely omitted during protoplast preparation of Z. officinale embryogenic cell suspensions [24,80]. Pretreatment also has certain side effects. Therefore, selecting an appropriate pretreatment method will optimize the efficiency and quality of medicinal plant protoplast preparation. 4.2.2. Composition of Enzymatic Hydrolysis Solution The optimal composition of the enzymatic hydrolysis solution for protoplast isolation varies among different medicinal plant materials. The key to protoplast preparation is selecting the appropriate cell wall-degrading enzymes based on differences in cell wall components across species [93]. Enzymes used for cell wall degradation mainly include Cellulase, Hemicellulase, and Pectinase, with friable or meristematic tissues primarily requiring Hemicellulase and Pectinase [56,88]. Additionally, using a single enzyme may result in partial degradation of the plant cell wall, leading to reduced protoplast yield [94]. Cellulase is often used in combination with Macerozyme, Driselase, and Pectolyase for protoplast isolation [42]. There are significant differences in the adaptability of various medicinal plant species with cell wall-degrading enzymes. Among the four commonly used enzymes, Macerozyme-R10 is the most suitable for the preparation of E. ulmoides protoplasts, with the best enzymatic hydrolysis efficiency [14]. In C. sativa leaf materials, adding Pectolyase significantly increased the yield of protoplasts [64]. Optimizing the enzyme solution concentration is another critical step in protoplast preparation [94]. Enzyme concentrations higher than 2% w/v can shorten enzyme incubation time, but usually damage the integrity of plant cell membranes and reduce the protoplast activity [88]. The gradient concentration test showed that treatment with 1.5% Cellulase-R10 yielded the highest C. morifolium ‘White ND’ leaf protoplasts production [42]. Systematic screening of enzyme combinations confirms that the mixed enzyme solution consisting of 2% Cellulase-R10, 0.5% Cellulase-RS, 0.5% Macerozyme-R10, 0.5% Hemicellulase, and 1% Pectinase can achieve efficient protoplast isolation from A. melilotoides embryogenic calli [81]. In summary, targeted optimization of enzyme species, combinations, and concentrations based on material characteristics is key to efficient protoplast preparation from medicinal plants. 4.2.3. Enzymatic Hydrolysis Time and Rotation Speed Enzymatic hydrolysis time is a core parameter for balancing the yield and viability of protoplasts [91]. Insufficient digestion time leads to incomplete cell wall degradation and low protoplast yield, whereas excessive enzymatic digestion causes cellular damage and reduces protoplast viability [14]. The time of enzymatic digestion required for protoplast release ranges from 4 to 10 h, depending on the type of plant material [95]. Young leaf tissues are suitable for shorter enzymatic digestion times. Research has found that 4–5 h of enzymatic hydrolysis achieved the highest protoplast yield and vitality of S. miltiorrhiza leaf protoplasts [24]. Mechanical shaking can accelerate the enzymatic hydrolysis and isolation process of plant protoplasts, and is an important physical parameter that affects the efficiency of protoplast enzymatic hydrolysis [88,91]. During plant protoplast digestion, the stirring speed of the enzyme solution on an orbital shaker typically ranges from 0 to 90 rpm, with an average of approximately 40 rpm [91]. Research has shown that gentle shaking resulted in a higher protoplast yield of G. biloba leaf protoplasts compared to static incubation [12]. Selecting appropriate enzymatic hydrolysis time and rotation speed based on plant species or tissue characteristics can, to a certain extent, improve the efficiency and quality of medicinal plant protoplast preparation. 4.2.4. Temperature, pH, and Osmotic Pressure Temperature, pH, and the osmotic pressure of the enzyme solution are also important factors affecting protoplast release. Temperature exerts a dual regulatory effect on protoplast preparation. Studies have shown that within a certain range, a gradual increase in temperature generally leads to a gradual rise in the number of prepared protoplasts [13]. However, high temperatures may cause a slight decrease in enzyme activity, which in turn reduces protoplast yield and activity [13]. It can also increase the fluidity of the receptor cell membrane, which may lead to premature lysis of protoplasts during centrifugation, resulting in their destruction. To avoid thermal damage, the incubation temperature for protoplast preparation should not exceed 35 °C, and most plant protoplasts can be stably isolated at room temperature (23–28 °C) [88,96]. Consistent with this principle, 28 °C is the optimal temperature for the enzymatic digestion of G. biloba calli for protoplast production [11]. The pH of the enzymatic hydrolysis solution can indirectly affect digestion efficiency by regulating the activity of cell wall-degrading enzymes [97]. Mannitol is a commonly used osmotic pressure regulator, and the optimal mannitol concentration for maintaining plant cell osmotic pressure in general studies ranges from 0.4 to 0.6 M [12]. Notably, higher osmotic pressure induces lower protoplast isolation efficiency, while lower osmotic pressure leads to more protoplast rupture [67]. Meanwhile, osmotic concentration directly affects the activity of cell wall-degrading enzymes. Protoplast isolation from C. sativa leaf has demonstrated that pectolyase performs significantly better in 0.4 M mannitol than in 0.7 M mannitol [40]. 4.2.5. Protoplast Purification Methods Protoplast purification primarily focuses on removing large debris, such as cell tissues and undigested cell clusters, that affect the physiological state of protoplasts. Protoplast purification relies on various factors, such as nylon membrane pore size, centrifugation speed, and sucrose gradient centrifugation [56]. Protoplasts can be easily separated from incompletely digested tissues and harvested by adjusting the sieve pore size [88]. After enzymatic hydrolysis, the crude protoplast extract has a complex composition, potentially containing undigested tissues, cell clusters, and debris. It is commonly filtered through a 40–400 mesh cell sieve to obtain high-purity protoplasts [57]. Comparative studies have confirmed that pore sizes ranging from 20 μm to 88 μm differently affect the integrity of L. corniculatus leaf protoplasts, indicating that filtration parameters should be tailored to material characteristics [70]. Specifically, 44 μm and 62 μm nylon sieves yield higher protoplast integrity than 20 μm and 88 μm sieves [70]. Centrifugal speed exhibits a bidirectional effect: excessively high centrifugal force exerts strong pressure on protoplasts, easily causing severe damage; conversely, insufficient centrifugal force prevents complete collection of protoplasts [73]. Protoplast purification should be performed under gentle and low-speed centrifugation conditions, with particular care to avoid excessive centrifugal forces [56]. The gradient speed screening experiment evaluated 700 rpm as the optimal centrifugation parameter for protoplast isolation from R. communis leaf, achieving the maximum protoplast vitality (80.34%) [73]. Sucrose gradient centrifugation purifies viable protoplasts by removing cell wall debris and dead cells, and is a commonly used method for protoplast purification [98]. In sucrose gradient purification, sucrose concentration directly affects the banding and recovery of intact protoplasts. A 25% sucrose solution was confirmed optimal for purifying C. morifolium ‘White ND’ leaf protoplasts [42]. 4.3. Brief Summary Intrinsic variables, including the species of medicinal plants, the growth state of plant materials, and tissues of plant materials, and process variables, including pretreatment methods before enzymatic hydrolysis, the composition of the enzymatic hydrolysis solution, enzymatic hydrolysis time, rotation speed during enzymatic hydrolysis, external environmental factors, and the adopted protoplast purification method, can affect the efficiency of the enzymatic hydrolysis process, and further influence the yield and activity of the prepared protoplasts (Table 1). Cellulase combined with Macerozyme represents the most widely used enzyme combination in published research. Mechanical cutting, as the most frequently adopted pretreatment approach, is applicable to various medicinal plant species and explant types, delivering highly repeatable experimental results. Compared to herbaceous medicinal plants, woody medicinal plants typically require additional pectinase to enhance cell wall degradation efficiency due to their higher degree of lignification. Leaf is the most commonly selected explant material for protoplast isolation in herbaceous medicinal plants. Based on multiple studies, pretreatment methods, enzyme proportions, and mannitol concentration are the most significant process variables affecting protoplast preparation efficiency. The common biological principles supporting successful protoplast isolation are as follows: through the coordinated regulation of pretreatment methods, enzymatic digestion parameters, and external osmotic conditions, cell walls derived from different species and tissues are specifically degraded at a suitable enzymatic digestion efficiency, with the integrity of the cell membrane structure and cellular physiological activity maintained to the maximum extent. Based on the systematic comparison of intrinsic material traits and operational processing parameters, several practical design guidelines are concluded for protoplast preparation. Intrinsic variables, including medicinal plant species, explant types, and plant growth status, directly determine protoplast yield and viability. Young leaves and friable calli serve as the dominant materials for protoplast isolation, and herbaceous medicinal plants have been far more extensively studied than recalcitrant woody species. Process variables such as pretreatment, enzyme, time, rotation speed, temperature, pH, osmotic pressure, and protoplast purification methods exert dual effects on protoplasts, each with a corresponding optimal level. Moreover, the ideal isolation system varies greatly among different medicinal plant species. 5. Applications of Protoplasts Due to the absence of a cell wall, medicinal plant protoplasts can easily integrate exogenous genetic material, facilitating plant genetic transformation and holding great application prospects for gene function verification, somatic cell genetics, cell regulation, crop improvement, and breeding (Figure 2). 5.1. Transient Expression of Medicinal Plant Protoplasts 5.1.1. Methods for Transient Expression of Medicinal Plant Protoplasts Plant protoplasts are naked plant cells lacking a rigid cell wall and are well-known as efficient transformation tools in botanical research [27]. Protoplasts are widely used for genetic transformation due to their ability to dedifferentiate, proliferate, regenerate, and adsorb exogenous DNA [41]. Protoplast transient expression systems play a vital role in medicinal plant genetic improvement, gene function verification, and secondary metabolism research [115]. Various transient expression systems for medicinal plant protoplasts have been established, including the most commonly used PEG-mediated method and electroporation [87]. PEG-mediated method refers to the exogenous DNA that interferes with the surface potential of the cell membrane phospholipid bilayer through PEG, and enters the protoplast recipient cell [12] (Figure 3). To date, the PEG method has been mostly used in transient plasmid transformation of medicinal plant protoplasts, such as Taxus, S. miltiorrhiza, A. catechu, U. rhynchophylla, E. ulmoides, P. ternata, G. biloba, A. senticosus, P. kurrooa, P. ginseng, F. esculentum, C. tinctorius, and C. sativa [11,13,14,15,24,38,40,41,51,59,62,64,76,77,78,100,104,110,115]. Electroporation is a widely used physical transfection method in molecular and cell biology, which delivers exogenous DNA into protoplasts by placing them in a high electric field, low capacitance electric shock environment [12,116]. However, the reversible pores generated by electroporation may be difficult to self-repair in some cell membranes, leading to cell death due to content leakage [12]. A study employed electroporation technology to introduce the CrWRKY1 promoter/GUS plasmid into protoplasts of C. roseus cell suspension cultures and monitored the activity of its promoter fragments [117]. PEG-mediated transient transfection is a commonly used method for genetic manipulation of medicinal plant protoplasts, but this method is species dependent, and the characteristics of the technology itself also impose certain constraints on its downstream application scenarios, such as gene editing and cell regeneration. 5.1.2. Applications of Transient Expression in Promoter Analysis Transient gene overexpression technology is suitable for plant protoplasts lacking stable genetic transformation systems, advancing research on gene function [12]. At present, several reporter genes, such as GUS, LUC, and GFP, have been successfully introduced into plant protoplasts [118]. Protoplast transient expression systems provide a physiological context for predicting promoter [119]. Multiple representative studies have fully demonstrated the versatility and effectiveness of this system. Specifically, the activation mechanism of the VRE1-CaMV35S minimal promoter was elucidated in Euphorbia pulcherrima protoplasts, confirming its dependence on VIP1 nuclear localization [120]. The crucial promoter regions for activity of the CrWRKY1 promoter were defined via 5′ and 3′ terminal deletion analysis using C. roseus protoplasts [117]. The activities of four C. tinctorius flavonoid biosynthesis-related promoters (pctCHI-1, pctCHS-2, pctF3H-2, and pctGT-1) were characterized in safflower using a protoplast expression system [110]. Additionally, the function of the auxin response element DR5 synthetic promoter was verified in C. sativa protoplasts by flow cytometry [64]. Therefore, medicinal plant protoplast transient expression systems not only provide an efficient platform for deciphering gene expression regulatory mechanisms but also reveal the promoter functions. 5.1.3. Applications of Transient Expression in Gene Identification Due to their lack of a cell wall, protoplasts serve as ideal hosts for efficient co-transfection of multiple exogenous DNAs [56]. This technology has been widely applied in the functional exploration of the genes of various medicinal plants. Subcellular localization, protein–protein interaction, and transient overexpression experiments using G. biloba protoplasts enabled systematic analysis of gene functions and their regulatory networks [12]. Subcellular localization experiments confirmed the specific localization to the nucleus of the transcription factor UrWRKY37 in U. rhynchophylla protoplasts [13]. Transient expression in R. communis mesophyll protoplasts was used to elucidate the biochemical characteristics of RcFATA protein, which is a fatty acyl–acyl carrier thioesterase [73]. The functional roles of BIS1, CrMYC2, and CrJAZ1 were analyzed using transient gene expression assays in C. roseus protoplasts [121]. Additionally, transient overexpression of CmMBF1c in protoplasts of the waterlogging-sensitive C. morifolium cultivar ‘Qinglu’ revealed the molecular mechanism by which CmMBF1c improves waterlogging tolerance by reducing ROS accumulation [122]. The combination of protoplast transient expression and BiFC technology is commonly used for protein interaction studies in medicinal plant protoplasts [56,123]. To date, this technology has been widely applied to the functional characterization of regulatory proteins and the activity analysis of metabolic enzymes in both woody and herbaceous medicinal plants, covering species such as G. biloba, C. roseus, and C. tinctorius [11,12,121,124]. Plant protoplasts can serve as a transient expression system to rapidly analyze the target genes of transcription factors, acting as an efficient experimental model for studying transcription factor activity. 5.2. Gene Editing Research Protoplast transient transfection technology is widely used in gene silencing and genome editing research due to its high-efficiency screening characteristics [87]. Protoplasts combined with newly developed technologies, such as RNAi and CRISPR/Cas9, can be used for gene silencing and editing in different plant species [39]. RNAi technology represents an effective paradigm for elucidating plant stress resistance mechanisms. In C. morifolium, comparative analysis between waterlogging-sensitive and tolerant cultivars revealed that CmMBF1c positively regulates waterlogging tolerance by reducing ROS accumulation and enhancing ROS scavenging gene expression [122]. At present, protoplasts mainly use the CRISPR/Cas9-mediated gene editing system to evaluate the efficiency of genome editing mutagenesis, and this technology has been applied in various medicinal plants, such as S. miltiorrhiza, C. sativa, Dioscorea spp., and Ganoderma lucidum [24,50,51,125,126]. In addition to CRISPR/Cas9, the programmable nuclease TnpB is substantially smaller than Cas9 and has been successfully applied for gene editing in diverse medicinal plants, including Artemisia annua, S. miltiorrhiza, Scutellaria baicalensis, Isatis indigotica, and C. pilosula, holding great promise for molecular breeding to enhance crop yield and quality [127]. In recent years, protoplast-mediated genome editing has achieved substantial advances, including DNA-free genome editing, Cas12 systems, base editing, prime editing, ribonucleoprotein delivery, and multiplex editing, greatly expanding the precision editing toolbox for medicinal plants [128,129,130,131,132,133]. Therefore, combined with emerging gene editing technologies, medicinal plant protoplasts can be used for rapid silencing of target genes, providing an efficient method for studying the functions of key genes in secondary metabolic pathways and facilitating precise regulation and improvement of medicinal active ingredient synthesis. 5.3. Single-Cell Sequencing Single-cell sequencing technologies, including scDNA-seq, scRNA-seq, and single-cell epigenomic sequencing, can construct high-dimensional maps of individual cells in isolated samples [134,135]. The presence of a cell wall makes plant single-cell isolation more challenging than that of an animal cell, resulting in a relatively limited scale of application of single-cell sequencing in plants [136]. The preparation of protoplasts is a necessary step for single-cell sequencing of medicinal plants. Using single-cell sequencing technology, distinct gene expression patterns of C. roseus, G. pentaphyllum, H. perforatum, D. longan, and Taxus wallichiana var. mairei were revealed within heterogeneous cell populations [36,65,71,107,108,137]. scRNA-seq technology overcomes the limitations of traditional bulk sequencing, enabling high-resolution analysis of cell heterogeneity, providing single-cell-level molecular regulatory mechanisms for precision breeding and metabolic engineering [138]. Conventional protoplast-based scRNA-seq technology faces two major challenges: digestion-induced transcriptional artifacts and the loss of fragile cell types [138,139]. To overcome this limitation, snRNA-seq has emerged as a highly promising alternative that bypasses the requirement for protoplast isolation and effectively circumvents transcriptional perturbations arising from enzymatic digestion [140]. In addition, the integration of single-cell transcriptomics with spatial transcriptomics effectively compensates for the spatial information loss inherent in cell dissociation, enabling precise spatial localization of cell subpopulations and a deeper understanding of their physiological functions [141]. 5.4. Cell Fusion Protoplasts are important raw materials for plant cell fusion technology (also called somatic hybridization), which can break through reproductive isolation between distant species, achieve gene recombination, and create new varieties with excellent traits from two species [56]. Protoplast fusion technology enables asexual transfer of genetic material, facilitating the renewal of germplasm resources and improving breeding efficiency. A standard cell fusion strategy typically includes four key steps: isolating parental protoplasts, inducing protoplast fusion through chemical (PEG-mediated) or electrical stimulation, culturing heterokaryons to regenerate hybrid calli, and screening target somatic hybrid lines [142]. Compared with model plants, research on protoplast fusion in medicinal plants is relatively limited, mainly through chemical PEG stimulation of protoplast fusion, such as Kitagawia terebinthacea/Bupleurum chinense, D. candidum/G. pentaphyllum, Z. officinale ‘Lushan Zhangliang jiang’/Z. officinale ‘Chenggu Huang Jiang’, B. scorzonerifolium/Taxus chinensis var. mairei and J. sambac/J. mesnyi [72,101,143,144,145]. Protoplast cell fusion technology enhances the construction of efficient metabolic systems, offering revolutionary prospects for germplasm innovation, seed propagation, and crop variety improvement. 5.5. Plant Regeneration A protoplast, an isolated naked plant cell, can regenerate a cell wall, undergo dedifferentiation and mitosis to form calli, and further develop an adventitious shoot and root or somatic embryo, ultimately regenerating a whole plant [88,100,146]. By evaluating a large number of protoplast-regenerated plants, it is expected to screen mutants with ideal traits [147]. Compared with model plants and cash crops, most investigations on medicinal plant protoplasts are merely limited to cell wall regeneration, while systems capable of whole plant regeneration remain scarce. Several representative documented advances are summarized as follows: C. sativus, P. ternata, Rh. sachalinensis, C. morifolium ‘White ND’, A. gigas, S. miltiorrhiza, P. amurense, Z. officinale, C. pilosula, P. cordata, A. melilotoides, S. dulcamara, E. cardamomum, L. usitatissimum, L. corniculatus, S. album, S. nigrum, P ginseng, B. scorzonerifolium, P. praeruptorum, S. xanthocarpum, Rehmannia glutinosa, C. roseus, and L. barbarum [18,22,25,42,43,50,67,68,70,74,75,78,79,80,81,83,102,103,106,109,111,112,113,114,148,149,150]. The regeneration efficiency of plant protoplasts is constrained by both intrinsic and extrinsic factors. Genotype effects cause marked differences in dedifferentiation and redifferentiation capacity across species and tissue sources, with most recalcitrant species failing to regenerate whole plants [151]. Hormonal regulation is limited by the poor stability of natural hormones and the species-specific hormonal requirements, hindering the generalizability of regeneration systems [57]. Epigenetic barriers suppress the expression of key regeneration genes, leading to abnormal regeneration [152]. Oxidative stress during protoplast isolation leads to excessive ROS accumulation [153]. Without timely antioxidant systems, protoplasts suffer oxidative damage, resulting in cellular structural disruption and cell division, which hinder plant regeneration [153]. Furthermore, the overaccumulation of ROS triggers somaclonal variation, resulting in unstable regeneration efficiency, abnormal phenotypes, and metabolic disorders [154]. Whole plant regeneration of protoplasts derived from most medicinal plants currently relies on the indirect organogenesis pathway of “calli-adventitious shoot and root-regenerated plant”, laying a material foundation for germplasm innovation and efficient production of bioactive metabolites. 6. Conclusions The medicinal plant protoplast transformation system has important roles in rapid, high-throughput, and large-scale deciphering of promoter and gene functions. However, overall, the number of fully established medicinal plant protoplast preparation and transformation systems is much smaller than that of model plants and crops. To date, protoplast isolation systems have been successfully established for a wide range of medicinal plant species, mainly herbaceous plants. Plant materials are the foundation for isolating protoplasts from medicinal plants. Before isolating medicinal plant protoplasts via enzymatic hydrolysis, pretreatment methods, such as vacuum treatment, dark treatment, pre-plasmolysis treatment, low-temperature treatment, and mechanical cutting, can be applied to increase protoplast yield and purity. For the purification of medicinal plant protoplasts, multiple factors, such as sieve pore size, centrifugation speed, and sucrose concentration, should be considered. Application of the medicinal plant protoplast transient transfection system enables rapid detection of promoter activity, elucidation of signal transduction pathways, identification of gene functions, and verification of the regulatory network. Although gene function verification systems have been established, medicinal plant protoplasts also serve as ideal recipients for gene silencing and gene editing technologies. In addition, the single-cell characteristics of protoplasts can be utilized to analyze the molecular regulatory mechanisms in medicinal plants. At present, the regeneration of whole medicinal plants starting from protoplasts mostly takes callus formation as an intermediate step, followed by the gradual differentiation of adventitious buds and roots, and ultimately developing into a complete plant individual. Protoplast technology can effectively overcome the inherent limitations of medicinal plants. However, it still faces numerous bottlenecks. Due to genotype dependence, medicinal plants generally exhibit species and tissue specificity, making it difficult to establish efficient and stable systems for protoplast preparation, purification, and transient expression. Existing research on gene editing, single-cell sequencing, and protoplast fusion remains largely limited to a few species. The scalability for large-scale breeding programs is insufficient. In addition, most protoplast fusion experiments are conducted on model plants such as tobacco. Most regeneration studies only achieve cell wall reconstruction and callus induction, and whole-plant regeneration from protoplasts suffers from poor controllability. In addition, there is a lack of standardized protocols among different research groups regarding enzyme batches, physiological states of plant materials, and culture conditions, resulting in poor reproducibility across laboratories. Protoplast biotechnology has shown considerable economic potential in medicinal plant breeding and metabolic engineering. Subsequently, economic competitiveness should focus on enzyme recycling, domestic equipment substitution, and synthetic biology-driven optimization. To promote medicinal plant protoplast technology from fundamental laboratory research toward industrial application and large-scale breeding programs, future studies can focus on the following four directions. First, AI-assisted parameter optimization remains a long-term prospective hypothesis for protoplast isolation that, despite rapid advances in enzyme engineering, awaits empirical validation, with future potential to predict optimal conditions by integrating multidimensional constraints. Second, the delivery protocol of CRISPR RNP complexes into protoplasts should be refined through material modification and fine-tuning of experimental conditions, so as to improve the efficiency and biosafety of transgene-free gene editing. Third, automated workflow platforms and high-throughput screening systems should be integrated with microfluidic devices or automated equipment to improve experimental stability and adaptability for large-scale breeding. Fourth, protoplast technology should be deeply integrated with spatial transcriptomics and multi-omics to dissect the regulatory networks and cellular heterogeneity of secondary metabolic pathways in medicinal plants at the single-cell level. Through interdisciplinary integration of AI, multi-omics analysis, and synthetic biology, a comprehensive system covering upstream material preparation and downstream experimental applications can be established. This system provides strong technical support for new variety breeding, targeted genetic improvement, metabolic engineering of bioactive products, and ecological conservation breeding.